Jaguar Health
(NASDAQ) JAGX
Jaguar Health Financials at a Glance
Market Cap
$1.57M
Revenue (TTM)
$11.79M
Net Income (TTM)
$40.29M
EPS (TTM)
$-33.98
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Price
$0.41
Volume
40
Open
$0.42
Price
$0.41
Volume
40
Open
$0.42
Previous Close
$0.41
Daily Range
$0.41 - $0.42
52-Week Range
$0.40 - $15.48
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Price
$0.41
Volume
40
Open
$0.42
Previous Close
$0.41
Daily Range
$0.41 - $0.42
52-Week Range
$0.40 - $15.48
JAGX News
JAGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jaguar Health
Industry
Pharmaceuticals
Sector
Health CareEmployees
49
CEO
Lisa A. Conte, MBA
Website
www.jaguar.healthHeadquarters
San Francisco, CA 94104, US
JAGX Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-371%
Return on Capital
-2%
Return on Assets
-81%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.57M
Shares Outstanding
3.74M
Volume
40
Short Interest
0.00%
Avg. Volume
3.83M
Financials (TTM)
Gross Profit
$9.73M
Operating Income
$30.83M
EBITDA
$36.66M
Operating Cash Flow
$29.38M
Capital Expenditure
$231.00K
Free Cash Flow
$29.61M
Cash & ST Invst.
$8.00M
Total Debt
$36.53M
Jaguar Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.08M
-0.8%
Gross Profit
$1.99M
-22.4%
Gross Margin
64.58%
N/A
Market Cap
$1.57M
N/A
Market Cap/Employee
$31.98K
N/A
Employees
49
N/A
Net Income
$9.50M
+3.6%
EBITDA
$9.08M
-36.2%
Quarterly Fundamentals
Net Cash
$28.37M
-35.1%
Accounts Receivable
$1.44M
+10.0%
Inventory
$10.63M
+9.9%
Long Term Debt
$8.57M
-61.8%
Short Term Debt
$23.33M
+96.8%
Return on Assets
-81.45%
N/A
Return on Invested Capital
-2.46%
N/A
Free Cash Flow
$4.74M
+25.0%
Operating Cash Flow
$4.69M
+26.1%